Dow Up 0.59% Nasdaq Up 0.75%

Alcobra Ltd. (ADHD)

-NasdaqGM
17.23 Up 0.75(4.55%) 4:00PM EDT
|After Hours : 17.10 Down 0.13 (0.75%) 4:23PM EDT
Prev Close:16.48
Open:16.35
Bid:17.10 x 200
Ask:18.75 x 100
1y Target Est:33.63
Beta:1.935
Earnings Date:Nov 3 - Nov 7 (Est.)
Day's Range:16.27 - 17.31
52wk Range:13.63 - 26.96
Volume:158,673
Avg Vol (3m):160,478
Market Cap:235.40M
P/E (ttm):N/A
EPS (ttm):-1.54
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for ADHD

Comparison

Symbol% ChgMkt Cap
ADHDUp 4.55%235.40M
JNJUp 1.11%298.61B
NVSUp 0.21%228.99B
SHPGUp 0.87%50.61B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-2.18
Quarterly EPS Est (Sep-14) :-0.56
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Alcobra Ltd., a biopharmaceutical company, focuses on the development and commercialization of proprietary drug candidates. It offers most advanced product (MDX) for the treatment of attention deficit hyperactivity disorder (ADHD) and other cognit... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback